Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Erytech Pharma SA (DE:2E4A)
FRANKFURT:2E4A
Erytech Pharma SA (DE:2E4A) Stock Price & Analysis
0 Followers
2E4A Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.19 - €1.68
Previous Close€0.71
Volume0.00
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)N/A
Beta2.05
Next EarningsMar 13, 2023
EPS Estimate-€0.17
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)N/A
Shares Outstanding31,016,053
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Price to Book (P/B)0.81
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
AlphaN/A
Number of Analyst Covering0
2E4A FAQ
What was Erytech Pharma SA’s price range in the past 12 months?
Erytech Pharma SA lowest stock price was €0.19 and its highest was €1.68 in the past 12 months.
What is Erytech Pharma SA’s market cap?
Currently, no data Available
When is Erytech Pharma SA’s upcoming earnings report date?
Erytech Pharma SA’s upcoming earnings report date is Mar 13, 2023 which is in 34 days.
How were Erytech Pharma SA’s earnings last quarter?
Erytech Pharma SA released its earnings results on Nov 21, 2022. The company reported -€0.163 earnings per share for the quarter, beating the consensus estimate of -€0.329 by €0.166.
Is Erytech Pharma SA overvalued?
According to Wall Street analysts Erytech Pharma SA’s price is currently Overvalued.
Does Erytech Pharma SA pay dividends?
Erytech Pharma SA does not currently pay dividends.
What is Erytech Pharma SA’s EPS estimate?
Erytech Pharma SA’s EPS estimate is -€0.17.
How many shares outstanding does Erytech Pharma SA have?
Currently, no data Available
What happened to Erytech Pharma SA’s price movement after its last earnings report?
Erytech Pharma SA reported an EPS of -€0.163 in its last earnings report, beating expectations of -€0.329. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Erytech Pharma SA?
Currently, no hedge funds are holding shares in DE:2E4A
---
Erytech Pharma SA Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.15%
12-Months-Change
Fundamentals
Return on Equity
-93.47%
Trailing 12-Months
Asset Growth
-30.59%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Erytech Pharma SA
ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. It engages in developing and producing therapeutic products for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
---
---